Baxter International is a US company operating worldwide in the pharmaceutical and medical technology sectors. The company produces drugs for anesthesiology and intensive care medicine, vaccines and medical devices.
According to Baxter's latest financial reports the company's total debt is ยฃ7.55 Billion. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2024-12-31 | ยฃ10.71 B | -3.26% |
2023-12-31 | ยฃ11.07 B | -22.1% |
2022-12-31 | ยฃ14.21 B | 4.83% |
2021-12-31 | ยฃ13.56 B | 171.74% |
2020-12-31 | ยฃ4.99 B | 9.81% |
2019-12-31 | ยฃ4.54 B | 65.58% |
2018-12-31 | ยฃ2.74 B | 5.65% |
2017-12-31 | ยฃ2.59 B | 15.26% |
2016-12-31 | ยฃ2.25 B | -48.65% |
2015-12-31 | ยฃ4.39 B | -24.29% |
2014-12-31 | ยฃ5.79 B | 4.36% |
2013-12-31 | ยฃ5.55 B | 51.46% |
2012-12-31 | ยฃ3.66 B | 9.77% |
2011-12-31 | ยฃ3.34 B | 17.61% |
2010-12-31 | ยฃ2.84 B | 10.79% |
2009-12-31 | ยฃ2.56 B | 0.1% |
2008-12-31 | ยฃ2.56 B | 64.82% |
2007-12-31 | ยฃ1.55 B | 8.74% |
2006-12-31 | ยฃ1.42 B | -26.12% |
2005-12-31 | ยฃ1.93 B | -13.46% |
2004-12-31 | ยฃ2.23 B | -12.53% |
2003-12-31 | ยฃ2.55 B | -11.77% |
2002-12-31 | ยฃ2.89 B | 56.39% |
2001-12-31 | ยฃ1.85 B | 17.2% |
2000-12-31 | ยฃ1.58 B | -10.54% |
1999-12-31 | ยฃ1.76 B | -12.71% |
1998-12-31 | ยฃ2.02 B | 19.69% |
1997-12-31 | ยฃ1.69 B | 41.93% |
1996-12-31 | ยฃ1.19 B |
Company | Total debt/th> | differencediff. | Country |
---|---|---|---|
![]() Cardinal Health CAH | ยฃ5.62 B | -25.51% | ๐บ๐ธ USA |
![]() Stryker Corporation SYK | ยฃ12.29 B | 62.78% | ๐บ๐ธ USA |
![]() Boston Scientific BSX | ยฃ8.58 B | 13.57% | ๐บ๐ธ USA |
![]() Becton Dickinson BDX | ยฃ14.12 B | 86.92% | ๐บ๐ธ USA |
![]() Halozyme Therapeutics HALO | ยฃ1.10 B | -85.38% | ๐บ๐ธ USA |
![]() Thermo Fisher Scientific TMO | ยฃ25.05 B | 231.64% | ๐บ๐ธ USA |
![]() CryoLife CRY | N/A | N/A | ๐บ๐ธ USA |
![]() Owens & Minor
OMI | ยฃ1.66 B | -77.97% | ๐บ๐ธ USA |
![]() Medtronic MDT | ยฃ19.50 B | 158.09% | ๐ฎ๐ช Ireland |
![]() ICU Medical
ICUI | ยฃ1.17 B | -84.48% | ๐บ๐ธ USA |